Skip to main content
SpringerLink
Log in

Pharmaceutical Risk-Sharing Agreements

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cook JP, Vernon JA, Manning R. Pharmaceutical risk-sharing agreements. Pharmacoeconomics 2008; 26 (7): 551–6

    Article  PubMed  Google Scholar 

  2. de Pouvourville G. Risk-sharing agreements for innovative drugs: a new solution to old problems? Eur J Health Econ 2006 Sep; 7 (3): 155–7

    Article  PubMed  Google Scholar 

  3. Arrow K, Lind R. Risk and uncertainty: uncertainty and the evaluation of public investment decisions. Am Econ Rev 1970; 60: 364–78

    Google Scholar 

  4. Al MJ, Feenstra TL, van Hout BA. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty. Health Econ 2005; 14: 655–67

    Article  PubMed  Google Scholar 

  5. Graff Zivin J. Cost-effectiveness analysis with risk aversion. Health Econ 2001; 10: 499–508

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, USA

    Afschin Gandjour

Authors
  1. Afschin Gandjour
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gandjour, A. Pharmaceutical Risk-Sharing Agreements. Pharmacoeconomics 27, 431–432 (2009). https://doi.org/10.2165/00019053-200927050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200927050-00007

Keywords

Search

Navigation